Skip to main content
. 2019 Dec 26;19:1080. doi: 10.1186/s12879-019-4669-9

Table 3.

The comparison of drugs treatment used between 50 severe acute respiratory infection (sARI) cases and 79 controls infected with pH1N1 influenza

Drugs Number exposed Percent exposed Matched odds ratioa (95%CI) Conditional logistic regression
Case (N = 50) Control (N = 79) Case Control
Glucocorticosteroidsb 30 5 60.0 6.3 16.7(5.8–47.7) 8.2(2.3–29.0)
Pyrazolonesc 15 6 30.0 7.6 4.7(1.6–13.7) 3.3(0.8–14.6)
Neuraminidase inhibitor 37 7 74.0 8.9 24.5(8.7–68.4) 14.8(4.9–45.2)
Amantidine 3 6 6.0 7.6 0.9(0.2–3.8)
Ribavirin 27 36 54.0 45.6 1.3(0.6–2.8)
Other antivirals 15 32 30.0 40.5 0.6(0.2–1.3)
Antibiotics 47 67 94.0 84.8 3.4(0.8–13.4) 1.0(0.2–5.5)
Acetaminophen 15 17 30.0 21.5 1.7(0.7–3.8)
Ibuprofen 15 16 30.0 20.3 2.1(0.9–5.0) 2.1(0.7–7.1)
Nimesulide 9 15 18.0 19.0 1.0(0.4–2.7)
Traditional Chinese medicine 33 59 66.0 74.7 0.5(0.2–1.2)

aOdds Ratio is matched by underlying disease, bdexamethasone or methyl prednisolone, caminopyrine or dipyrone